Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report.

Kinza T AhmadHana A MansourBenjamin T RollinsSergio Pina OviedoPaul H PhillipsSami H Uwaydat

Published in: Case reports in ophthalmological medicine (2021)

Anti-VEGF agents may decrease the ophthalmologic complications of RAH. We recommend that this treatment should be started early and continued for a protracted time at regular and frequent intervals. Moreover, a combination of therapies might prove to be superior to monotherapy and should therefore be considered in aggressive retinal astrocytic hamartomas.

Keyphrases

vascular endothelial growth factor
diabetic retinopathy
optical coherence tomography
endothelial cells
combination therapy
optic nerve
risk factors
clinical trial
randomized controlled trial
newly diagnosed